- Home
- FVRR vs MDXG Comparison
FVRR vs MDXG Comparison
Compare FVRR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- MDXG
- Stock Information
- Founded
- FVRR 2010
- MDXG 2006
- Country
- FVRR Israel
- MDXG United States
- Employees
- FVRR N/A
- MDXG N/A
- Industry
- FVRR Business Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- MDXG Health Care
- Exchange
- FVRR Nasdaq
- MDXG Nasdaq
- Market Cap
- FVRR 1.1B
- MDXG 1.0B
- IPO Year
- FVRR 2019
- MDXG N/A
- Fundamental
- Price
- FVRR $32.42
- MDXG $6.43
- Analyst Decision
- FVRR Buy
- MDXG Strong Buy
- Analyst Count
- FVRR 12
- MDXG 2
- Target Price
- FVRR $35.00
- MDXG $12.50
- AVG Volume (30 Days)
- FVRR 648.6K
- MDXG 852.6K
- Earning Date
- FVRR 05-07-2025
- MDXG 04-30-2025
- Dividend Yield
- FVRR N/A
- MDXG N/A
- EPS Growth
- FVRR 127.71
- MDXG N/A
- EPS
- FVRR 0.49
- MDXG 0.27
- Revenue
- FVRR $405,141,000.00
- MDXG $352,375,000.00
- Revenue This Year
- FVRR $12.96
- MDXG $9.44
- Revenue Next Year
- FVRR $8.66
- MDXG $11.54
- P/E Ratio
- FVRR $66.68
- MDXG $23.82
- Revenue Growth
- FVRR 10.41
- MDXG 5.34
- 52 Week Low
- FVRR $20.78
- MDXG $5.47
- 52 Week High
- FVRR $36.11
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- FVRR 62.99
- MDXG 38.95
- Support Level
- FVRR $30.89
- MDXG $6.46
- Resistance Level
- FVRR $33.07
- MDXG $6.90
- Average True Range (ATR)
- FVRR 1.06
- MDXG 0.23
- MACD
- FVRR -0.09
- MDXG -0.05
- Stochastic Oscillator
- FVRR 50.29
- MDXG 1.02
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.